Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative
Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative |
|
https://doi.org/10.18632/oncotarget.27338
Elena Fountzilas,
Vassiliki Kotoula,
Georgia-Angeliki Koliou,
Eleni Giannoulatou,
Helen Gogas,
Christos Papadimitriou,
Ioannis Tikas,
Jianhua Zhang,
Kyriaki Papadopoulou,
Flora Zagouri,
Christos Christodoulou,
Angelos Koutras,
Thomas Makatsoris,
Sofia Chrisafi,
Helena Linardou,
Ioannis Varthalitis,
George Papatsibas,
Evangelia Razis,
Pavlos Papakostas,
Epaminontas Samantas,
Gerasimos Aravantinos,
Dimitrios Bafaloukos,
Paris Kosmidis,
Anna Koumarianou,
Amanda Psyrri,
Georgios Pentheroudakis,
Dimitrios Pectasides,
Andrew Futreal,
George Fountzilas,
and Apostolia M. Tsimberidou
|
| 1-14 |
Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer
Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.27408
Marcus Moses,
Ulkuhan Koksal,
Elisa Ledet,
Charlotte Manogue,
Patrick Cotogno,
Brian Lewis,
Jodi Layton,
A. Oliver Sartor,
and Pedro Barata
|
| 15-21 |
PDLIM4/RIL-mediated regulation of Src and malignant properties of breast cancer cells
PDLIM4/RIL-mediated regulation of Src and malignant properties of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.27410
Dmitry Sergeevich Kravchenko,
Anna Evgenyevna Ivanova,
Elizaveta Sergeevna Podshivalova,
and Stepan Petrovich Chumakov
|
| 22-30 |
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers |
|
https://doi.org/10.18632/oncotarget.27414
Kouki Okita,
Shogo Okazaki,
Shinya Uejima,
Erina Yamada,
Hiroki Kaminaka,
Misa Kondo,
Shiho Ueda,
Ryo Tokiwa,
Nami Iwata,
Akitaka Yamasaki,
Natsumi Hayashi,
Dai Ogura,
Kenji Hirotani,
Toshiaki Yoshioka,
Masahiro Inoue,
Kazue Masuko,
and Takashi Masuko
|
| 31-45 |
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas |
|
https://doi.org/10.18632/oncotarget.27416
Xiaochun Wang,
Reichelle X. Yeo,
Philip J. Hogg,
David Goldstein,
Philip Crowe,
Pierre J. Dilda,
and Jia-Lin Yang
|
| 46-61 |
Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer
Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27417
Jae-Sung Kim,
Daeun Lee,
Donggyu Kim,
Seok-Jun Mun,
Euni Cho,
Wooic Son,
and Chul-Su Yang
|
| 62-73 |
A novel function of AAA-ATPase p97/VCP in the regulation of cell motility
A novel function of AAA-ATPase p97/VCP in the regulation of cell motility |
|
https://doi.org/10.18632/oncotarget.27419
Zi-Jia Khong,
Soak-Kuan Lai,
Cheng-Gee Koh,
Susana Geifman-Shochat,
and Hoi-Yeung Li
|
| 74-85 |
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer |
|
https://doi.org/10.18632/oncotarget.27423
Yoshimasa Miyagawa,
Ayako Yanai,
Takehiro Yanagawa,
Junichi Inatome,
Chiyomi Egawa,
Arisa Nishimukai,
Kaori Takamoto,
Takashi Morimoto,
Yuichiro Kikawa,
Hirofumi Suwa,
Tomoe Taji,
Ai Yamaguchi,
Yuki Okada,
Atsushi Sata,
Reiko Fukui,
Ayako Bun,
Hiromi Ozawa,
Tomoko Higuchi,
Yukie Fujimoto,
Michiko Imamura,
and Yasuo Miyoshi
|
| 86-98 |
Identification of signature genes associated with therapeutic resistance to anti-VEGF therapy
Identification of signature genes associated with therapeutic resistance to anti-VEGF therapy |
|
https://doi.org/10.18632/oncotarget.27307
Pharavee Jaiprasart,
Samrita Dogra,
Deepika Neelakantan,
Bharat Devapatla,
and Sukyung Woo
|
| 99-114 |
Correction: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer
Correction: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27377
Xinghua Zhang,
Xiao Ma,
Huaying An,
Changqing Xu,
Wenjo Cao,
Wei Yuan,
and Jie Ma
|
| 115-115 |
